Bronchiolitis Obliterans Syndrome (BOS) Completed Phase Trials for Salbutamol (DB01001)

Also known as: Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01255449Respiratory Impedance and Obliterative BronchiolitisDiagnostic